GLRE
Greenlight Capital Re, Ltd.
GLRE trails on the overall score without a compensating advantage in the available component scores.
JPM
JPMorgan Chase & Co.
JPM has the edge over GLRE overall, supported by stronger modeled upside and stronger fundamentals.
GLRE Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| N/A | |
| N/A |
GLRE's profitability is currently healthy, but its revenue is under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like GLRE.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
GLRE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.1x | $8.62 | -47% |
| Fair | 7.5x | $12.69 | -22% |
| Current | 9.7x | $16.36 | — |
| Expensive | 15x | $25.44 | +56% |
Historical ranges are pointers, not guarantees.
GLRE's PE is in its fair range at 9.7x.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over GLRE in the historical PE scenario, which offers more potential upside but is not a forecast.
GLRE Forward outlook
There aren't enough analyst estimates for GLRE to show an outlook.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
GLRE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $1.69 | +$1.73 |
| Q2 2026 | $1.46 | +33% |
| Q1 2026 | $2.36 | +79% |
| Q4 2025 | $2.17 | +75% |
| Q3 2025 | -$0.04 | -102% |
| Q2 2025 | $1.10 | -46% |
| Q1 2025 | $1.32 | -58% |
| Q4 2024 | $1.24 | -50% |
GLRE has returned to profit: it earned $1.69 per share over the past year, after losing money the year before.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over GLRE on earnings, with more consistent year-over-year improvement.
GLRE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $148.3M | +1.5% |
| Q2 2026 | $137.5M | -14% |
| Q1 2026 | $189.7M | -11% |
| Q4 2025 | $210.3M | +48% |
| Q3 2025 | $146.1M | -22% |
| Q2 2025 | $160.1M | -8.4% |
| Q1 2025 | $213.3M | +11% |
| Q4 2024 | $141.8M | -8.8% |
GLRE's revenue fell from its 2025 peak and has held roughly level since: $148M last quarter, up 1.5% from the same quarter a year ago.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the edge over GLRE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM's operating margin was 40% last quarter, about level with the same quarter a year ago.
GLRE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.9M | -84% |
| Q2 2026 | $31.4M | -54% |
| Q1 2026 | $37.2M | +259% |
| Q4 2025 | $100.2M | +239% |
| Q3 2025 | $31.2M | -25% |
| Q2 2025 | $68.4M | +201% |
| Q1 2025 | $10.4M | -42% |
| Q4 2024 | $29.5M | +33% |
GLRE has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
GLRE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +104K shares |
| 1 year | -1.6% | -548K shares |
| 3 years | -4.6% | -1.6M shares |
| 5 years | +0.9% | +283K shares |
| Available history | -8.1% | -2.9M shares |
GLRE has 33M diluted shares, down 1.6% from a year ago, with $30M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $8M |
| Q2 2026 | $14.2M |
| Q1 2026 | $5M |
| Q4 2025 | $2.8M |
| Q3 2025 | $2M |
| Q4 2024 | — |
| Q3 2024 | $7.5M |
| Q4 2023 | — |
GLRE spent $30M buying back its own shares over the past year.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over GLRE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
GLRE Net Leverage
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
GLRE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.0 | Neutral |
| Stochastic | 52.0 | Neutral |
GLRE's weekly RSI is 58 (neutral) and its Stochastic is 52 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
GLRE PE vs Financial Services Sector
| Metric | GLRE | Sector median | Relative |
|---|---|---|---|
| PE | 9.7x | 13x | 26% below |
| PE % | 58 | 63 | 5 pts below |
GLRE has the edge over JPM on valuation relative to its sector.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
GLRE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $15.2 | 7.8% above |
| 20 week MA | $15.6 | 4.7% above |
| 50 week MA | $15.6 | 4.7% above |
| 100 week MA | $14.5 | 13% above |
| 200 week MA | $13.1 | 25% above |
GLRE has the edge over JPM on trend strength, trading above more of its moving averages.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
GLRE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.1 | $7.16 | -29% |
| 2021 | $7.16 | $7.40 | +3.4% |
| 2022 | $7.40 | $8.09 | +9.3% |
| 2023 | $8.09 | $11.4 | +41% |
| 2024 | $11.4 | $13.8 | +21% |
| 2025 | $13.8 | $14.4 | +4.3% |
| 2026 YTD | $14.4 | $16.4 | +13% |
GLRE has the edge over JPM on returns for 2026, with the stronger performance.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.